Pregled bibliografske jedinice broj: 349481
Virtual Screening and Experimental Verification to Identify Potential Inhibitors of the ErmC Methyltransferase Responsible for Bacterial Resistance against Macrolide Antibiotics
Virtual Screening and Experimental Verification to Identify Potential Inhibitors of the ErmC Methyltransferase Responsible for Bacterial Resistance against Macrolide Antibiotics // ChemMedChem, 3 (2008), 2; 316-322 doi:10.1002/cmdc.200700201 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 349481 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Virtual Screening and Experimental Verification to Identify Potential Inhibitors of the ErmC Methyltransferase Responsible for Bacterial Resistance against Macrolide Antibiotics
Autori
Feder, Marcin ; Purta, Elzbieta ; Koscinski, Lukasz ; Čubrilo, Sonja ; Maravić Vlahoviček, Gordana ; Bujnicki, Janusz M.
Izvornik
ChemMedChem (1860-7179) 3
(2008), 2;
316-322
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
antibiotic resistance; ErmC methyltransferase; inhibitors; macrolides; modeling; virtual screening
Sažetak
Methyltransferases from the Erm family catalyze S-adenosyl-L-methionine-dependent modification of a specific adenine residue in bacterial 23S rRNA, thereby conferring resistance to clinically important macrolide, lincosamide, and streptogramin B antibiotics. Thus far, no inhibitors of these enzymes have been identified or designed that would effectively abolish the resistance in vivo. We used the crystal structure of ErmC methyltransferase as a target for structure-based virtual screening of a database composed of 58 679 lead-like compounds. Among 77 compounds selected for experimental validation (63 predicted to bind to the catalytic pocket and 14 compounds predicted to bind to the putative RNA binding site), we found several novel inhibitors that decrease the minimal inhibitory concentration of a macrolide antibiotic erythromycin toward an Escherichia coli strain that constitutively expresses ErmC. Eight of them have IC50 values in the micromolar range. Analysis of docking models of the identified inhibitors suggests a novel strategy to develop potent and clinically useful inhibitors.
Izvorni jezik
Engleski
Znanstvena područja
Biologija
POVEZANOST RADA
Projekti:
006-0982913-1219 - Molekularne osnove djelovanja antibiotika i mehanizmi bakterijske rezistencije (Maravić Vlahoviček, Gordana, MZOS ) ( CroRIS)
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- BIOSIS Previews (Biological Abstracts)
- CA Search (Chemical Abstracts)
- Compendex (EI Village)
- EMBASE (Excerpta Medica)
- Geobase
- International Pharmaceutical Abstracts (IPA)
- MEDLINE